|Articles|May 3, 2017
George Clinical Acquires Vector Oncology
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division.
Advertisement
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division. This acquisition aims to assist George Clinical in providing oncology trial delivery solutions throughout the Asia-Pacific region.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5